FULC

3.89

3.18% 0.12

Dopo l'orario di chiusura: 3.89

Fulcrum Therapeutics Inc (FULC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$3.77

Aprire:

$3.83

Volume 24 ore:

1.46M

Relative Volume:

0.62

Capitalizzazione di mercato:

$259.20M

Reddito:

$80.00M

Utile/perdita netta:

$-76.12M

Rapporto P/E:

-3.3929

EPS:

-1.1465

Flusso di cassa netto:

$-63.88M

1 W Prestazione:

+8.66%

1M Prestazione:

+3.18%

6M Prestazione:

-60.06%

1 anno Prestazione:

-42.88%

Intervallo 1D:

$3.77

$3.91

Intervallo di 1 settimana:

$3.544

$3.91

Portata 52W:

$2.83

$15.74

Fulcrum Therapeutics Inc Stock (FULC) Company Profile

Nome

Fulcrum Therapeutics Inc

Settore

Healthcare (1077)

Industria

Biotechnology (602)

Telefono

617-651-8851

Indirizzo

26 LANDSDOWNE STREET, CAMBRIDGE, MA

Dipendente

Cinguettio

@fulcrumtx

Prossima data di guadagno

2026-08-04

Ultimi documenti SEC

FULC's Discussions on Twitter

Compare FULC vs VRTX, REGN, ARGX, RVMD, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
FULC Fulcrum Therapeutics Inc	3.89	248.54M	80.00M	-76.12M	-63.88M	-1.1465
VRTX Vertex Pharmaceuticals Inc	496.07	121.57B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	784.36	69.95B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	865.04	55.61B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	205.15	39.98B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	348.27	33.81B	5.76B	514.49M	1.10B	4.4813

Fulcrum Therapeutics Inc Stock (FULC) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-01-12	Iniziato	JP Morgan	Overweight
2025-11-24	Iniziato	Truist	Buy
2025-07-29	Aggiornamento	H.C. Wainwright	Neutral → Buy
2025-05-23	Aggiornamento	Leerink Partners	Market Perform → Outperform
2025-05-15	Aggiornamento	Cantor Fitzgerald	Neutral → Overweight
2024-09-13	Downgrade	H.C. Wainwright	Buy → Neutral
2024-09-12	Downgrade	BofA Securities	Neutral → Underperform
2024-09-12	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2024-09-12	Downgrade	Leerink Partners	Outperform → Market Perform
2024-09-12	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2024-09-12	Downgrade	Stifel	Buy → Hold
2024-09-09	Aggiornamento	BofA Securities	Underperform → Neutral
2024-05-20	Iniziato	Cantor Fitzgerald	Overweight
2024-03-13	Iniziato	RBC Capital Mkts	Outperform
2023-09-25	Iniziato	Goldman	Neutral
2023-08-23	Aggiornamento	H.C. Wainwright	Neutral → Buy
2023-08-22	Aggiornamento	Stifel	Hold → Buy
2023-05-04	Downgrade	Goldman	Buy → Neutral
2023-03-10	Downgrade	Credit Suisse	Outperform → Neutral
2023-03-10	Downgrade	H.C. Wainwright	Buy → Neutral
2023-03-09	Downgrade	Stifel	Buy → Hold
2023-02-28	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2023-02-24	Downgrade	BofA Securities	Neutral → Underperform
2022-11-15	Iniziato	Goldman	Buy
2022-03-08	Iniziato	Oppenheimer	Outperform
2022-03-03	Aggiornamento	BofA Securities	Underperform → Neutral
2021-08-11	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2021-04-26	Ripresa	Credit Suisse	Outperform
2021-03-22	Iniziato	Credit Suisse	Outperform
2021-03-02	Iniziato	Stifel	Buy
2020-10-16	Iniziato	Piper Sandler	Overweight
2020-08-12	Downgrade	BofA Securities	Neutral → Underperform
2020-08-12	Reiterato	H.C. Wainwright	Buy
2020-08-12	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-06-19	Downgrade	BofA/Merrill	Buy → Neutral
2020-06-17	Iniziato	BTIG Research	Buy
2019-10-03	Iniziato	H.C. Wainwright	Buy
2019-08-12	Iniziato	BofA/Merrill	Buy

Mostra tutto

Fulcrum Therapeutics Inc Borsa (FULC) Ultime notizie

Jul 28, 2026